Note: Ingredients listed on restricted chemical lists
EC/CAS
205-483-3/141-43-5
Name of the chemical
2-aminoethanol
Concentration
≥25-≤50
General Information
Version
2.01
Revision date
2026-02-03
Product name
TEKNOPAINT ADDITIVE 7902-00 - PH ADJUSTMENT
1.2.1 Relevant identified uses
Additive
Icons in SDS
Company Information
company name
Teknos Group Oy
e-mail address of the competent person responsible for the Safety Data Sheet
Prod-safe@teknos.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H314, H318, H335
Hazard statements
Code
Statements
H314
Causes severe skin burns and eye damage
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Danger
Hazard statements
H314 - Causes severe skin burns and eye damage. H335 - May cause respiratory irritation.
Prevention
P280 - Wear protective gloves, protective clothing and eye or face protection.
Response
P304 + P310 - IF INHALED: Immediately call a POISON CENTER or doctor. P301 + P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor. P303 + P361 + P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water.
Storage
P403 + P233 - Store in a well-ventilated place. Keep container tightly closed.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Contains
2-aminoethanol
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Skin Corr. 1, H314 Eye Dam. 1, H318 STOT SE 3, H335 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
